account_balance
Investment manager · 13F filer · SEC CIK 1778253
Ikarian Capital, LLC
Reported value$611Mas of Jun 30, 2026
Positions126 27 new, 28 sold out
Top 10 weight39.5%ABVX alone is 7%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
ABVXAbivax SA
7.1%Added +470%
KODKodiak Sciences Inc
6.8%Trimmed −16%
ALMSAlumis Inc
4.0%Trimmed −28%
PRAXPraxis Precision Medicines I
4.0%
PCVXVaxcyte Inc
3.7%Trimmed −9%
ANIPAni Pharmaceuticals Inc
3.7%Added +85%
CLDXCelldex Therapeutics Inc New
2.9%Added +4%
RCUSArcus Biosciences Inc
2.5%New
RLMDRelmada Therapeutics Inc
2.4%Trimmed −20%
CAPRCapricor Therapeutics Inc
2.4%Added +14%
COGTCogent Biosciences Inc
2.3%New
VERAVera Therapeutics Inc
2.2%Added +55%
ABVXAbivax SA
7.1%Added +470%
KODKodiak Sciences Inc
6.8%Trimmed −16%
ALMSAlumis Inc
4.0%Trimmed −28%
PRAXPraxis Precision Medicines I
4.0%
PCVXVaxcyte Inc
3.7%Trimmed −9%
ANIP3.7%CLDX2.9%RCUS2.5%RLMD2.4%CAPR2.4%COGT2.3%VERA2.2%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
ABVX Abivax SA 7.1% Added +470%KOD Kodiak Sciences Inc 6.8% Trimmed −16%ALMS Alumis Inc 4.0% Trimmed −28%PRAX Praxis Precision Medicines I 4.0% HeldPCVX Vaxcyte Inc 3.7% Trimmed −9%ANIP Ani Pharmaceuticals Inc 3.7% Added +85%CLDX Celldex Therapeutics Inc New 2.9% Added +4%RCUS Arcus Biosciences Inc 2.5% NewRLMD Relmada Therapeutics Inc 2.4% Trimmed −20%CAPR Capricor Therapeutics Inc 2.4% Added +14%COGT Cogent Biosciences Inc 2.3% NewVERA Vera Therapeutics Inc 2.2% Added +55%
What changed